Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
This product is an oral SYK inhibitor and suppresses platelet destruction by macrophages and platelet depletion
The inspection, which is a routine part of the FDA's regulatory oversight, evaluates compliance with Good Manufacturing Practices and other regulatory requirements.
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
The biosimilar Ustekinumab has been developed and manufactured by the company
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
The company's portfolio includes 21 commercialized products, 19 approved ANDAs, 4 CGT designations, 6 filed ANDAs, and 45 products in its pipeline
Subscribe To Our Newsletter & Stay Updated
